Bright Minds Biosciences (DRUG) Non-Current Assets (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Non-Current Assets of $52778.4 for Q1 2026, down 50.99% on a YoY basis from $107682.7 in Q1 2025, and down 20.15% quarter-over-quarter from $66100.3 in Q4 2025.
Bright Minds Biosciences (DRUG) Non-Current Assets (2020 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Non-Current Assets for 7 years, with the latest figure at $52778.4 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 50.99% year-over-year to $52778.4; the trailing twelve-month figure through Mar 2026 stood at $293322.2 (down 10.97% YoY), and the FY2025 full-year result was $81359.9, down 5.67% from the prior year.
- Non-Current Assets for Q1 2026 stood at $52778.4, down from $66100.3 in the prior quarter.
- The five-year high for Non-Current Assets was $126700.3 in Q4 2024, with the low at $8828.5 in Q2 2024.
- Historically, Non-Current Assets has averaged $70965.3 across 5 years, with a median of $75921.0 in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 6601.37% — and 2024, when it slumped 85.97%.
- Bright Minds Biosciences' Non-Current Assets stood at $88957.6 in 2022, then plunged by 60.12% to $35478.1 in 2023, then soared by 257.12% to $126700.3 in 2024, then tumbled by 47.83% to $66100.3 in 2025, then decreased by 20.15% to $52778.4 in 2026.
- The last three Non-Current Assets figures came in at $52778.4 (Q1 2026), $66100.3 (Q4 2025), and $81359.9 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 39.71 Mn |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | 52,778.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,778.45 |
| Dec 31, 2025 | 66,100.30 |
| Sep 30, 2025 | 81,359.87 |
| Jun 30, 2025 | 93,083.59 |
| Mar 31, 2025 | 107,682.66 |
| Dec 31, 2024 | 126,700.29 |
| Sep 30, 2024 | 86,249.60 |
| Jun 30, 2024 | 8,828.52 |
| Mar 31, 2024 | 22,402.91 |
| Dec 31, 2023 | 35,478.07 |
| Sep 30, 2023 | 49,539.48 |
| Jun 30, 2023 | 62,924.84 |
| Mar 31, 2023 | 75,920.96 |
| Dec 31, 2022 | 88,957.62 |
| Sep 30, 2022 | 106,472.68 |
| Sep 30, 2021 | 1,588.82 |
| Sep 30, 2020 | 1,500.85 |